We extend our sincere appreciation for the support of our corporate sponsors. Their generosity provides vital funding needed to fulfill our mission to make a lasting and positive difference in the lives of people who have kidney disease.
THANK YOU TO OUR CORPORATE PARTNERS
Fresenius Kidney Care, a division of Fresenius Medical Care North America (FMCNA), provides dialysis treatment and services to more than 190,000 people with kidney disease at more than 2,400 facilities nationwide. Fresenius Kidney Care supports people by helping to address both the physical and emotional aspects of kidney disease through personalized care, education and lifestyle support services so they can lead meaningful and fulfilling lives.
U.S. Renal Care serves more than 23,000 patients in 300 dialysis facilities in 31 states and the Territory of Guam with a unique business model, developing and operating dialysis centers in joint venture partnerships with leading local nephrologists.
Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.
Akebia was founded in 2007 to discover and develop therapeutic solutions leveraging the potential of hypoxia inducible factor—or HIF—biology. Akebia believes HIF-Prolyl Hydroxylase (HIF-PH) inhibition could represent an approach to treating certain conditions where there is unmet need.
RSN thanks The Crane Fund for Widows and Children for their generous support.
Dialysis Clinic, Inc. (DCI) is the nation’s largest non-profit dialysis provider with over 230 outpatient dialysis clinics in 28 states. DCI’s services include in-center hemodialysis, home hemodialysis, and Peritoneal Dialysis.
OneLegacy saves and heals lives through organ, eye and tissue donation, comforts the families we serve, and inspires our communities to Donate Life. OneLegacy envisions a day when we fulfill the needs of donor families and all who require organ, cornea or tissue transplants for their health and well-being. We commit ourselves to continuously improve the quality of our practices, performance, and service to our communities.
Mallinckrodt Pharmaceuticals is a multibillion dollar specialty pharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, stemming from 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future.